{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T22:49:30Z","timestamp":1778798970407,"version":"3.51.4"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T00:00:00Z","timestamp":1427500800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pharmacol Toxicol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40360-015-0005-1","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T20:35:52Z","timestamp":1427488552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cohort study of consistency between the compliance with guidelines for chemotherapy-induced nausea and vomiting and patient outcome"],"prefix":"10.1186","volume":"16","author":[{"given":"Masahiro","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatomo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,28]]},"reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bmj.1.6174.1323-a","volume":"1","author":"C Morran","year":"1979","unstructured":"Morran C, Smith DC, Anderson DA, McArdle CS. Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics. Br Med J. 1979;1:1323\u20134.","journal-title":"Br Med J"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1200\/JCO.1988.6.11.1746","volume":"6","author":"JL Richardson","year":"1988","unstructured":"Richardson JL, Marks G, Levine A. The influence of symptoms of disease and side effects of treatment on compliance with cancer therapy. J Clin Oncol. 1988;6:1746\u201352.","journal-title":"J Clin Oncol"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00001610-200511000-00003","volume":"28","author":"PD Baker","year":"2005","unstructured":"Baker PD, Morzorati SL, Ellett ML. The pathophysiology of chemotherapy-induced nausea and vomiting. Gastroenterol Nurs. 2005;28:469\u201380.","journal-title":"Gastroenterol Nurs"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1200\/jco.2006.24.18_suppl.8515","volume":"24","author":"E Basch","year":"2006","unstructured":"Basch E, Prestrud AA, Hesketh PJ, Kris MG, Feyer PC, Somerfield MR, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2006;24:2932\u201347.","journal-title":"J Clin Oncol"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/annonc\/mdp584","volume":"21","author":"M Aapro","year":"2010","unstructured":"Aapro M, Fabi A, Nol\u00e8 F, Medici M, Steger G, Bachmann C, et al. Double-blind, randomised, controlled study of the efficacy and tolerability of palonosetron plus dexamethasone for 1 day with or without dexamethasone on days 2 and 3 in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy. Ann Oncol. 2010;21:1083\u20138.","journal-title":"Ann Oncol"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/cncr.21222","volume":"104","author":"RJ Gralla","year":"2005","unstructured":"Gralla RJ, De Wit R, Herrstedt J, Carides AD, Ianus J, Guoguang-Ma J, et al. Antiemetic efficacy of the neurokinin-1 antagonist, aprepitant, plus a 5-HT3 antagonist and a corticosteroid in patients receiving anthracy-clines or cyclophosphamide in addition to high-dose cisplatin: analysis of combined data from two phase III randomized clinical trials. Cancer. 2005;104:864\u20138.","journal-title":"Cancer"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1634\/theoncologist.12-9-1143","volume":"12","author":"K Jordan","year":"2007","unstructured":"Jordan K, Sippel C, Schmoll HJ. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. Oncologist. 2007;12:1143\u201350.","journal-title":"Oncologist"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00520-005-0788-5","volume":"13","author":"CT Liau","year":"2005","unstructured":"Liau CT, Chu NM, Liu HE, Deuson R, Lien J, Chen JS. Incidence of chemotherapy-induced nausea and vomiting in Taiwan: physicians\u2019 and nurses\u2019 estimation vs. patients\u2019 reported outcomes. Support Care Cancer. 2005;13:277\u201386.","journal-title":"Support Care Cancer"},{"key":"5_CR9","unstructured":"MASCC Antiemesis Tool\u00a9 (MAT) [http:\/\/www.mascc.org\/mat]"},{"key":"5_CR10","doi-asserted-by":"crossref","unstructured":"Caracuel F, Mu\u00f1oz N, Ba\u00f1os U, Ramirez G. Adherence to antiemetic guidelines and control of chemotherapy-induced nausea and vomiting (CINV) in a large hospital. J Oncol Pharm Pract. 2014. [Epub ahead of print].","DOI":"10.1177\/1078155214524809"},{"key":"5_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.7314\/APJCP.2013.14.1.469","volume":"14","author":"CH Keat","year":"2013","unstructured":"Keat CH, Phua G, Abdul Kassim MS, Poh WK, Sriraman M. Can granisetron injection used as primary prophylaxis improve the control of nausea and vomiting with low-emetogenic chemotherapy? Asian Pac J Cancer Prev. 2013;14:469\u201373.","journal-title":"Asian Pac J Cancer Prev"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1089\/jpm.2011.0058","volume":"14","author":"JM Jones","year":"2011","unstructured":"Jones JM, Qin R, Bardia A, Linquist B, Wolf S, Loprinzi CL. Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy. J Palliat Med. 2011;14:810\u20134.","journal-title":"J Palliat Med"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"e414","DOI":"10.3747\/co.19.1074","volume":"19","author":"N Bouganim","year":"2012","unstructured":"Bouganim N, Dranitsaris G, Hopkins S, Vandermeer L, Godbout L, Dent S, et al. Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting. Curr Oncol. 2012;19:e414\u201321.","journal-title":"Curr Oncol"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s005200050158","volume":"6","author":"MG Kris","year":"1998","unstructured":"Kris MG, Roila F, De Mulder PH, Marty M. Delayed emesis following anticancer chemotherapy. Support Care Cancer. 1998;6:228\u201332.","journal-title":"Support Care Cancer"},{"key":"5_CR15","doi-asserted-by":"crossref","unstructured":"Kim HK, Hsieh R, Chan A, Yu S, Han B, Gao Y, et al. Impact of CINV in earlier cycles on CINV and chemotherapy regimen modification in subsequent cycles in Asia Pacific clinical practice. Support Care Cancer. 2014. [Epub ahead of print].","DOI":"10.1007\/s00520-014-2376-z"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1007\/s00520-013-1843-2","volume":"21","author":"A Molassiotis","year":"2013","unstructured":"Molassiotis A, Stamataki Z, Kontopantelis E. Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer. 2013;21:2759\u201367.","journal-title":"Support Care Cancer"}],"container-title":["BMC Pharmacology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-015-0005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40360-015-0005-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-015-0005-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40360-015-0005-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T09:49:47Z","timestamp":1630576187000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpharmacoltoxicol.biomedcentral.com\/articles\/10.1186\/s40360-015-0005-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,28]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1186\/s40360-015-0005-1","relation":{},"ISSN":["2050-6511"],"issn-type":[{"value":"2050-6511","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,28]]},"assertion":[{"value":"9 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}